MedGenome Labs
A genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome.
Launch date
Employees
Market cap
-
Enterprise valuation
€182—273m (Dealroom.co estimates Aug 2022.)
Foster City California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$4.0m | Series A | ||
$20.0m | Series B | ||
$30.0m | Series C | ||
$10.0m | Series C | ||
N/A | Early VC | ||
* | $55.0m | Series D | |
$16.5m Valuation: $275m | Late VC | ||
* | $50.0m | Late VC | |
Total Funding | €169m |
Recent News about MedGenome Labs
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by MedGenome Labs
EditACQUISITION by MedGenome Labs Feb 2016
ACQUISITION by MedGenome Labs Nov 2021
ACQUISITION by MedGenome Labs May 2023